Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Beck

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Vaccine|September 17, 2023
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.
MMWR. Morbidity and Mortality Weekly Report|February 10, 2022
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022Anastasia S Lambrou, Philip Shirk, Molly K Steele, et al.
American Journal of Human Genetics|April 2, 2013
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersJuliet D French, Maya Ghoussaini, Stacey L Edwards, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Vaccine|September 17, 2023
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.
MMWR. Morbidity and Mortality Weekly Report|February 10, 2022
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022Anastasia S Lambrou, Philip Shirk, Molly K Steele, et al.
American Journal of Human Genetics|April 2, 2013
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersJuliet D French, Maya Ghoussaini, Stacey L Edwards, et al.
Pageof 8